Cargando…
Soluble interleukin-6 receptor in the COVID-19 cytokine storm syndrome
Data suggest that interleukin (IL)-6 blockade could reduce mortality in severe COVID-19, yet IL-6 is only modestly elevated in most patients. Chen et al. describe the role of soluble interleukin-6 receptor (sIL-6R) in IL-6 trans-signaling and how understanding the IL-6:sIL-6R axis might help define...
Autores principales: | Chen, Luke Y.C., Biggs, Catherine M., Jamal, Shahin, Stukas, Sophie, Wellington, Cheryl L., Sekhon, Mypinder S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055165/ https://www.ncbi.nlm.nih.gov/pubmed/33899032 http://dx.doi.org/10.1016/j.xcrm.2021.100269 |
Ejemplares similares
-
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome
por: Chen, Luke Y.C., et al.
Publicado: (2020) -
Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
por: England, James T., et al.
Publicado: (2021) -
Assessing the importance of interleukin-6 in COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021) -
Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study
por: Stukas, Sophie, et al.
Publicado: (2022) -
Are all cytokine storms the same?
por: Panoskaltsis, Nicki
Publicado: (2021)